Contraception
Volume 82, Issue 4 , Pages 358-365 , October 2010

Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles

  • Thomas Rabe

      Affiliations

    • University Women's Hospital, Voß-Str. 9, D-69115 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 6221 567913; fax: +49 6221 560713.
    • ,
  • Elena Hartschuh

      Affiliations

    • Neuenheimer Landstr. 60, D-69120 Heidelberg, Germany
    • ,
  • Torsten Wahlstrom

      Affiliations

    • Laboratory of Pathology, Eira Hospital, Tehtaan Katu 28, SF-00150 Helsinki, Finland
    • ,
  • Kornelia Höschen

      Affiliations

    • Grunenthal GmbH, D-52099 Aachen, Germany
    • ,
  • Simone König

      Affiliations

    • Grunenthal GmbH, D-52099 Aachen, Germany

Received 18 September 2009 ,Revised 13 April 2010 ,Accepted 14 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0010-7824(10)00150-2

doi: 10.1016/j.contraception.2010.04.013

Contraception
Volume 82, Issue 4 , Pages 358-365 , October 2010

Article Tools

* Image Usage & Resolution